AZN.L AstraZeneca
£118.92 -2.36%
Europe · Pharmaceuticals & biotechnology
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.36%
YTD
-7.10%
P/E
—
P/B
—
ROE
—
Div yield
—
Beta
-0.07
Market cap
—
RSI (14)
44
Next earnings
—
Previous session
close of Oct 8, 2026 · EOD, no live order bookOpen
£120.32
Close
£118.92
VWAP (n/a)
—
Day high
£118.92
Day low
£118.92
Volume
4K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer
Yahoo Finance · Oct 8
AstraZeneca (AZN) Seeks FDA Approval for New Lung Cancer Treatment. Can It Fuel Oncology Growth?
Yahoo Finance · Oct 8
Pfizer's Oncology Outlook: Key Drivers to Watch Ahead of Q3 Results
Yahoo Finance · Oct 8
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
Yahoo Finance · Oct 8
Pharma’s $500B patent problem will come in waves — not as a cliff
Yahoo Finance · Oct 8
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
Yahoo Finance · Oct 8
Headlines via Yahoo Finance · links open the source · not an endorsement.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell AZN.L. Try it in the Lab to size a position and see the risk.